Nf1 and Gmcsf interact in myeloid leukemogenesis
- PMID: 10678181
- DOI: 10.1016/s1097-2765(00)80415-3
Nf1 and Gmcsf interact in myeloid leukemogenesis
Abstract
The NF1 tumor suppressor gene encodes neurofibromin, a GTPase-activating protein (GAP) for p21ras (Ras). Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML). Some heterozygous Nf1 mutant mice develop a similar myeloproliferative disorder (MPD), and adoptive transfer of Nf1-deficient fetal liver cells consistently induces this MPD. Human JMML and murine Nf1-deficient cells are hypersensitive to granulocyte-macrophage colony-stimulating factor (GM-CSF) in methylcellulose cultures. We generated hematopoietic cells deficient in both Nf1 and Gmcsf to test whether GM-CSF is required to drive excessive proliferation of Nf1-/- cells in vivo. Here we show that GM-CSF play a central role in establishing and maintaining the MPD and that recipients engrafted with Nf1-/- Gmcsf-/- hematopoietic cells are hypersensitive to exogenous GM-CSF.
Similar articles
-
Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.Blood. 2003 Mar 1;101(5):1984-6. doi: 10.1182/blood-2002-08-2635. Epub 2002 Oct 17. Blood. 2003. PMID: 12393498
-
In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells.Blood. 1999 Oct 1;94(7):2469-76. Blood. 1999. PMID: 10498620
-
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.Blood. 2007 Feb 15;109(4):1687-91. doi: 10.1182/blood-2006-05-025395. Epub 2006 Nov 7. Blood. 2007. PMID: 17090653 Free PMC article.
-
Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations.Paediatr Drugs. 2012 Jun 1;14(3):157-63. doi: 10.2165/11631360-000000000-00000. Paediatr Drugs. 2012. PMID: 22480363 Review.
-
Inherited predispositions and hyperactive Ras in myeloid leukemogenesis.Pediatr Blood Cancer. 2006 May 1;46(5):579-85. doi: 10.1002/pbc.20644. Pediatr Blood Cancer. 2006. PMID: 16261595 Review.
Cited by
-
The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis.Neurooncol Adv. 2019 Oct 18;1(1):vdz037. doi: 10.1093/noajnl/vdz037. eCollection 2019 May-Dec. Neurooncol Adv. 2019. PMID: 32642666 Free PMC article. Review.
-
A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve.J Neurosci. 2002 Nov 15;22(22):9831-40. doi: 10.1523/JNEUROSCI.22-22-09831.2002. J Neurosci. 2002. PMID: 12427839 Free PMC article.
-
Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.Leukemia. 2017 Jun;31(6):1415-1422. doi: 10.1038/leu.2016.326. Epub 2016 Nov 14. Leukemia. 2017. PMID: 27840422 Free PMC article.
-
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.J Clin Invest. 2013 Jan;123(1):329-34. doi: 10.1172/JCI66167. Epub 2012 Dec 10. J Clin Invest. 2013. PMID: 23221339 Free PMC article.
-
Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.Dig Dis Sci. 2006 Jun;51(6):1043-6. doi: 10.1007/s10620-006-8003-1. Dig Dis Sci. 2006. PMID: 16865565 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous